pedigrees previously described (Fine et al, 1989) . The second family was not included in the study, as only the proband showed evidence of blister formation, suggesting a sporadic mutation. Briefly, the affected individuals studied here belong to a five-generation pedigree with an autosomal dominant pattern of inheritance (Figure 1a) . In affected family members, variably sized clefts were noted just beneath the level of the stratum corneum in each biopsy specimen (Fine et al, 1989) . In some, clefts were subcorneal; in others, lower intraepidermal. In none of the affected individuals was sub-lamina densa cleavage noted, nor was any diminution of type VII collagen staining noted using the anti-type VII antibody LH 7:2 (Fine et al, 1989) .
A genome-wide screen was performed using a panel of 324 microsatellite markers, with an average marker spacing of 10 cM and a semiautomated fluorescence-based genotyping system (Aita et al, 1999) . Two-point linkage analyses were carried out using the MLINK program of the FASTLINK suite of programs (Lathrop et al, 1984; Cottingham et al, 1993; Schaffer et al, 1994) . A disease allele frequency of 0.001 and an autosomal dominant mode of inheritance with complete penetrance were assumed. The marker allele frequencies were estimated from observed and reconstructed genotypes of founders within the pedigree. To avoid computation errors due to observed allele frequencies of 0.0, alleles for all markers were re-coded using the RECODE program (Weeks, 2000) . Multipoint analyses and reconstruction of pedigrees were carried out using the SIMWALK program version , lies within this genetic interval. Type VII collagen is the main constituent of the anchoring fibrils and at the microscopic level, DEB is characterized by skin cleavage beneath the lamina densa. The morphologic defect is a reduced number or complete absence of the anchoring fibrils, in the dominant and recessive forms of DEB, respectively (Tidman and Eady, 1985) . In DEB skin, blisters appear just beneath an intact lamina densa. In contrast, the family we studied and reported by Fine et al(1989) showed blister formation just beneath the stratum corneum. On the basis of the differences in phenotype between these two subtypes of EB, the COL7A1gene was not considered to be a candidate gene for EBSS.
Nevertheless, to unequivocally rule out this possibility, we performed heteroduplex analysis and direct sequencing of the coding region.
Quite unexpectedly, we identified a heterozygous transition in exon 73, 6100G A, leading to the amino acid change G2034R ( Table I) Table I ). The very same amino acid substitution has been described in three families with different forms of DDEB: the "Cockayne-Touraine" variant of DDEB (Kon et al, 1997) , DDEB "generalisata" (Hammami-Hauasli et al, 1998; Mecklenbeck et al, 1999) , and an unspecified subtype of DEB (Mecklenbeck et al, 1999 ). In addition, a different amino acid substitution affecting the same residue, G2034W, has also been reported. Rouan et al (1998 ) identified this second amino acid change in a family with a mild form of DDEB, mainly involving the hands, feet, and mouth. In another study, Mecklenbeck et al (1999) described the same mutation, G2034W, in two families with the so-called DDEB "localisata" ( Table I) . In these families, a clear DDEB phenotype has been reported, and these types of glycine substitution mutations are the most prevalent in DDEB.
In light of our results, we believe that the clinical phenotype in the EBSS kindred studied here actually represents a case of DDEB, rather than a unique subset of EBS. The molecular data suggest that the subcorneal cleavage observed in different members of this kindred would likely not be pathogenic or contribute to the disease process. As the proband from the second family reported in the original work (Fine et al, 1989) was not available for this study, these findings do not fully exclude the possibility that rare forms of EBS having superficial skin cleavage may also exist.
Although it is true that the family studied here does indeed have several clinical findings that are commonly associated with DEB, data from the National EB Registry have also shown that at least 10%-25% of all EBS patients have one or more of these "dystrophic" features as well, making the diagnosis based on clinical phenotypes sometimes imprecise. Genetic studies such as the one presented here become an invaluable tool to clarify the true molecular basis of a disease like EBSS, where the clinical features cannot be used to unequivocally classify a particular phenotype.
Collectively, these findings allow us to reclassify a previously uncharacterized form of EB as another clinical variant of DDEB.
